Update · Dec 21, 2025, 08:48 AMTrue
The Dana-Farber Cancer Institute has indeed agreed to pay $15 million to resolve allegations of violating the False Claims Act by making false statements concerning NIH research grants from 2014 to 2024. This agreement reflects a settlement to address claims related to improper certifications in their funding applications. Therefore, the statement is accurate as it stands.
Update · Dec 21, 2025, 07:37 AMTrue
The Dana-Farber Cancer Institute agreed to pay $15 million to settle allegations under the False Claims Act concerning false statements related to NIH research grants, consistent with the details provided in the source article. This accurately reflects the settlement amount and the allegations as stated. Therefore, the claim is verified as true.
Update · Dec 21, 2025, 06:52 AMTrue
According to the U.S. Department of Justice, Dana-Farber Cancer Institute has indeed agreed to pay $15 million to settle allegations under the False Claims Act concerning false statements related to NIH grants from 2014 to 2024. The settlement includes claims that the institute made materially false statements and certifications in its grant applications and reporting. Therefore, the statement is accurate as it aligns with the official announcement from the DOJ.
Update · Dec 21, 2025, 05:44 AMTrue
The statement is accurate; Dana-Farber Cancer Institute has indeed agreed to pay $15 million to resolve allegations concerning violations of the False Claims Act related to NIH grants, specifically involving materially false statements from 2014 to 2024. This settlement was formally detailed in a press release from the U.S. Department of Justice, confirming the claims and the associated financial penalties. Therefore, the verdict is True as it aligns with the official announcement and documentation.
Update · Dec 21, 2025, 04:56 AMTrue
The statement is accurate; Dana-Farber Cancer Institute has indeed agreed to pay $15 million to settle allegations related to the False Claims Act. The allegations involved making false statements regarding National Institutes of Health (NIH) grants between 2014 and 2024. Therefore, the claim is verified as truthful based on official sources from the Justice Department.
Update · Dec 21, 2025, 04:14 AMTrue
The Dana-Farber Cancer Institute has indeed agreed to pay $15 million to settle False Claims Act allegations involving NIH grants. The settlement addresses accusations that between 2014 and 2024, Dana-Farber made false statements and certifications connected to these research funds. The evidence from the Department of Justice confirms this agreement, affirming the accuracy of the claim.
Update · Dec 21, 2025, 02:45 AMTrue
The statement accurately reflects the terms of a settlement agreement where Dana-Farber Cancer Institute agreed to pay $15 million to resolve allegations under the False Claims Act regarding false statements related to NIH grants. The Justice Department's press release confirmed these allegations pertained to the period between 2014 and 2024. Therefore, the claim is true as it is supported directly by the official announcement from the Department of Justice.
Update · Dec 20, 2025, 11:38 PMTrue
The statement is accurate as Dana-Farber Cancer Institute has indeed agreed to pay $15 million to settle allegations of violating the False Claims Act by making false statements related to NIH research grants. This settlement covers the period from 2014 to 2024, as reported by the Justice Department. Therefore, the statement is verified based on the official announcement.
Update · Dec 20, 2025, 08:35 AMcomplete
The statement is accurate; Dana-Farber Cancer Institute has agreed to pay $15 million to resolve allegations under the False Claims Act related to NIH grants. These allegations involved making materially false statements and certifications concerning NIH research grants between 2014 and 2024. Therefore, the evidence confirms that the statement is true as stated.
Update · Dec 19, 2025, 07:25 AMcomplete
Dana-Farber Cancer Institute has indeed agreed to pay $15 million to settle allegations of violating the False Claims Act by making false statements related to NIH research grants between 2014 and 2024. This was confirmed by the U.S. Department of Justice in a press release. The statement accurately reflects the conclusions drawn from the official announcement, thus receiving a verdict of complete.
Update · Dec 18, 2025, 09:52 PMcomplete
The statement is accurate; Dana-Farber Cancer Institute agreed to pay $15 million to resolve allegations under the False Claims Act regarding NIH grants. According to the Department of Justice announcement, the violations occurred from 2014 to 2024, involving false statements and certifications related to NIH research funding. Therefore, the claim is validated by official statements.
Update · Dec 18, 2025, 07:23 PMcomplete
The Dana-Farber Cancer Institute has indeed agreed to pay $15 million to settle allegations of False Claims Act violations involving the submission of false information regarding NIH research grants from 2014 to 2024. This agreement was officially announced by the U.S. Department of Justice, confirming the accuracy of the statement. Therefore, the claim is complete as it aligns with the details provided by credible sources.
Update · Dec 18, 2025, 07:34 AMcomplete
The Dana-Farber Cancer Institute agreed to pay $15 million to settle allegations of violating the False Claims Act concerning NIH research grants. This settlement was confirmed in a press release by the U.S. Department of Justice, detailing the institute's false statements and certifications between 2014 and 2024. Therefore, the statement is accurate as it stands, supported by official government documentation.
Update · Dec 17, 2025, 03:06 PMcomplete
The statement is accurate; Dana-Farber Cancer Institute has indeed agreed to pay $15 million to settle allegations of violating the False Claims Act. This settlement addresses claims that the institute made false statements related to NIH research grants between 2014 and 2024 as reported by the U.S. Department of Justice.
Original article · Dec 16, 2025